89 related articles for article (PubMed ID: 6602239)
21. Immune response in experimentally induced uremia. V. Description of a model for chronic uremia in the rat that produces a long-term suppressive effect on T cell responses to mitogens.
Alevy YG; Mueller KR; Hutcheson P; Slavin RG
J Lab Clin Med; 1983 May; 101(5):717-25. PubMed ID: 6601172
[TBL] [Abstract][Full Text] [Related]
22. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
Buessow SC; Paul RD; Lopez DM
J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
[TBL] [Abstract][Full Text] [Related]
23. Correlation between changes in antitumor immune parameters and tumor growth in vivo in rats.
Bansal SC; Sjögren HO
Fed Proc; 1973 Feb; 32(2):165-72. PubMed ID: 4347409
[No Abstract] [Full Text] [Related]
24. Complex effects of long-term 50 Hz magnetic field exposure in vivo on immune functions in female Sprague-Dawley rats depend on duration of exposure.
Mevissen M; Häussler M; Szamel M; Emmendörffer A; Thun-Battersby S; Löscher W
Bioelectromagnetics; 1998; 19(4):259-70. PubMed ID: 9581968
[TBL] [Abstract][Full Text] [Related]
25. Decreased T cell response to mitogen and increased anti-cytoplasmic antibody in drug-free schizophrenic patients.
Matloubi H; Vodjgani M; Nasehi AA; Niknam MH; Kazemnejad A; Salehi E; Aboufazeli T; Gheflati Z
Iran J Immunol; 2007 Mar; 4(1):32-7. PubMed ID: 17652841
[TBL] [Abstract][Full Text] [Related]
26. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
27. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
Ishida T; Wang X; Shimizu T; Nawata K; Kiwada H
J Control Release; 2007 Oct; 122(3):349-55. PubMed ID: 17610982
[TBL] [Abstract][Full Text] [Related]
28. Suppression of mitogen-induced blastogenesis by the Trypanosoma cruzi-induced suppressor substance.
Cunningham DS; Benavides GR; Kuhn RE
J Parasitol; 1980 Oct; 66(5):722-9. PubMed ID: 6780676
[TBL] [Abstract][Full Text] [Related]
29. Ageing and immunity in outbred NMRI mice: lack of correlation between age-related decline of the response to T cell mitogens, the antibody response to a T-dependent antigen and lifespan in outbred NMRI mice.
Joncourt F; Kristensen F; De Weck AL
Clin Exp Immunol; 1981 May; 44(2):270-7. PubMed ID: 7030532
[TBL] [Abstract][Full Text] [Related]
30. Differences in spleen suppressor cell content in rats with progressing and regressing tumors.
Hollingsworth MA; Evans DL
J Natl Cancer Inst; 1982 Jul; 69(1):53-8. PubMed ID: 6212710
[TBL] [Abstract][Full Text] [Related]
31. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative.
Ghiringhelli F; Larmonier N; Schmitt E; Parcellier A; Cathelin D; Garrido C; Chauffert B; Solary E; Bonnotte B; Martin F
Eur J Immunol; 2004 Feb; 34(2):336-44. PubMed ID: 14768038
[TBL] [Abstract][Full Text] [Related]
32. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma.
Hoon DB; Ziola B; Ramshaw I
Cancer Res; 1984 Jun; 44(6):2406-9. PubMed ID: 6722781
[TBL] [Abstract][Full Text] [Related]
33. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762.
Frey AB
J Immunol; 1996 May; 156(10):3841-9. PubMed ID: 8621922
[TBL] [Abstract][Full Text] [Related]
34. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides.
Chagnon F; Tanguay S; Ozdal OL; Guan M; Ozen ZZ; Ripeau JS; Chevrette M; Elhilali MM; Thompson-Snipes LA
Clin Cancer Res; 2005 Feb; 11(3):1302-11. PubMed ID: 15709202
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the mitogenic reactivity of intestinal intraepithelial lymphocytes of chickens.
Agrawal PK; Reynolds DL
Avian Dis; 1999; 43(2):172-81. PubMed ID: 10396629
[TBL] [Abstract][Full Text] [Related]
37. Aberrant T-cell function in vitro and impaired T-cell dependent antibody response in vivo in vitamin A-deficient rats.
Wiedermann U; Hanson LA; Kahu H; Dahlgren UI
Immunology; 1993 Dec; 80(4):581-6. PubMed ID: 8307607
[TBL] [Abstract][Full Text] [Related]
38. Blood level of B and CD4+ lymphocytes measured before induction of an experimental tumor in rats predicts tumor progression and survival.
Demetrikopoulos MK; Goldfarb RH; Zhang ZB; Weiss JM
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):609-17. PubMed ID: 10868697
[TBL] [Abstract][Full Text] [Related]
39. A role for endogenous IL-12 in tumor immunity: IL-12 is required for the acquisition of tumor-migratory capacity by T cells and the development of T cell-accepting capacity in tumor masses.
Uekusa Y; Gao P; Yamaguchi N; Tomura M; Mukai T; Nakajima C; Iwasaki M; Takeuchi N; Tsujimura T; Nakazawa M; Fujiwara H; Hamaoka T
J Leukoc Biol; 2002 Nov; 72(5):864-73. PubMed ID: 12429708
[TBL] [Abstract][Full Text] [Related]
40. Presence of circulating immune complexes in patients with chronic lymphocytic leukaemia. Correlations between clinical and immunological features.
Mozzana R; Baldini L; Neri A; Cortelezzi A; Radaelli F; Colajori E; Polli EE
Boll Ist Sieroter Milan; 1982; 61(4):324-9. PubMed ID: 6927220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
